Clarinex-D Oral Tablet, Extended Release 24 Hour 5-240Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Clarinex-D: Oral tablet, extended release 24 hour (5-240mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5749.JPG
Clarinex-D 24Hr Tab
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: D 24 

What is this Medicine?

DESLORATADINE; PSEUDOEPHEDRINE (des lor AT a deen; soo doe e FED rin) is a combination of an antihistamine and a decongestant. This medicine is used to treat the symptoms of allergies. It reduces congestion, sneezing, runny nose, and itching.

CVS Pharmacy Patient Statistics for Clarinex-D: Oral tablet, extended release 24 hour(5-240mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Clarinex-D 24 Hour 5mg-240mg Extended-Release Tablet

NDC: 000851317
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Rhinitis, Nasal Congestion

Storage Information
Avoid temperatures above 86 degrees F
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Clarinex-D 24 Hour 5mg-240mg Extended-Release Tablet
Drug Image file DrugItem_5749.JPG
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: D 24 
Shape: oval
Color: blue

Reported Side Effects for Clarinex-D 24 Hour 5mg-240mg Extended-Release Tablet

Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Abnormal Heart Rhythm Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
2.0-4.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
>6.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Clarinex-D 24 Hour 5mg-240mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Clarinex-D 24 Hour 5mg-240mg Extended-Release Tablet(Pseudoephedrine Sulfate)
Caffeine-containing Foods/Beverages and Pseudoephedrine(Pseudoephedrine Sulfate)
Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Pseudoephedrine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Pseudoephedrine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.
Minor Lifestyle Interaction
Alcohol and Clarinex-D 24 Hour 5mg-240mg Extended-Release Tablet(Desloratadine)
Alcohol and Desloratadine(Desloratadine)
You may feel drowsy or more tired when taking this medicine with alcoholic beverages. Do not drive or operate machinery until you know how these drugs affect you.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Clarinex-D

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.